Pathological Response Is a Marker But Not a Cause of Good Prognosis in Rectal Cancer: 15-year Follow-up of the Lyon R90-01 Randomized Trial

Authors :: Jean-Pierre Gerard
Jérôme Doyen
Jean-Michel Hannoun-Levi
Eddy Cotte
Evelyne Decullier
Olivier Chapet
Source :: International Journal of Radiation Oncology*Biology*Physics. 93:S126
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Cancer Research
medicine.medical_specialty
Radiation
Colorectal cancer
business.industry
Pathological response
medicine.disease
Surgery
law.invention
Oncology
Randomized controlled trial
law
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Good prognosis
business

Full Text Access

Tools